FluBioVax(FluBioVax) - _专利_临床

概要

基本信息

药物类型

预防性疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

感染呼吸系统疾病

在研适应症-

非在研适应症

流感病毒感染

原研机构

ImmunoBiology Ltd.

在研机构-

非在研机构

ImmunoBiology Ltd.

最高研发阶段无进展临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 FluBioVax 相关的临床结果

登录后查看更多信息

100 项与 FluBioVax 相关的转化医学

登录后查看更多信息

100 项与 FluBioVax 相关的专利（医药）

登录后查看更多信息

1

项与 FluBioVax 相关的文献（医药）

2010-07-01·IDrugs : the investigational drugs journal

Vaccine Manufacturing--Second Annual visiongain Conference.

作者: McPherson, Clifton

The Vaccine Manufacturing--Second Annual visiongain Conference, held in London, included topics covering new technological developments in the field of influenza vaccine research. This conference report highlights selected presentations on influenza vaccine development in mammalian, insect and avian embryonic cells, regulatory considerations for cell culture-based influenza vaccine production, an improved animal model for influenza infection, and considerations for designing vaccine manufacturing facilities. Investigational drugs discussed include FluBiovax (Immunobiology Ltd) and FluBlok (Protein Sciences Corp/UMN Pharma Inc).

100 项与 FluBioVax 相关的药物交易

登录后查看更多信息